A Clinical Study of Lupron Depot in the Treatment of Women with Alzheimer's Disease: Preservation of Cognitive Function in Patients Taking an Acetylcholinesterase Inhibitor and Treated with High Dose Lupron Over 48 Weeks
Craig S. Atwood, Richard L. Bowen, George Perry, Mark A. Smith, Chengjie Xiong
Craig S. Atwood
Nothing to Disclose
Richard L. Bowen
Own stock in and was employed by Voyager Pharmaceutical Corp. which sponsored the study but has since filed for bankruptcy and is no longer in business.